The results paved the way for liraglutide, branded as Saxenda, to be approved in the US as a once-a-day subcutaneous injection in December 2014 and in Europe in 2015 for the treatment of chronic weight management combined with a reduced calorie diet and increased physical exercise (Molteni, Chen)
That doesnt mean the medications are necessarily causing these symptoms, but it could suggest that reports of menstrual changes and body temperature fluctuations are worth studying more systematically. Future Directions In the near term, the researchers hope their findings will encourage clinicians and researchers to take a closer look at the side effects patients are discussing online
This narrative review explores the current ML and artificial intelligence (AI) research landscape across several key domains, including early ASD screening, phenotypic stratification, diagnostic biomarkers, neuroimaging, personalised therapies, and the role of automation and robotics in the treatment of this complex condition
139, no
Expression of superoxide dismutase, glutathione peroxidase, and catalase increases[8]
Thats out of roughly 69 million people enrolled in Medicare nationwide, meaning even at launch, only around one in eighteen beneficiaries qualifies
